PRNewsWire - Health

REGENXBIO REPORTS NEW POSITIVE FUNCTIONAL DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
Avicenna.AI Secures CE Mark for Two Spine-Focused Medical Imaging AI Tools
Pawsitive Beginnings expands its animal-assisted therapy network with new partner and fox addition
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders